One hundred and ninety-eight clinical isolates of Mycobacterium kansasii collected between 2003 and 2004 in Japan were genotyped by PCR and restriction enzyme analysis (PRA) and 16S-23S internal transcribed spacer (ITS) sequencing. The results demonstrated that clinical isolates of M. kansasii in Japan are almost exclusively of the type I PRA genotype, as is the case in other countries. Although the results of subtyping using the 16S-23S ITS sequence were generally consistent with subtyping using hsp65 PRA, four strains showed a discrepancy between the two methods. Sequence analysis of the hsp65, gyrB and 16S rRNA genes and the ITS sequence of the four strains suggests that they branched from type II and could be considered an ancestral strain of the type I strain. The newly recognized strains were designated as intermediate type I.
Introduction
Mycobacterium kansasii is one of the most frequently isolated nontuberculous mycobacterial pathogen from clinical specimens (Choudhri et al., 1995) . Molecular typing methods demonstrated that M. kansasii is a heterogeneous species with several distinct subtypes (Ross et al., 1992; Alcaide et al., 1997; Iinuma et al., 1997; Picardeau et al., 1997; Richter et al., 1999; Gaafar et al., 2003; Taillard et al., 2003) . PCR and restriction enzyme analysis (PRA) of the hsp-65 gene has been widely applied to studies concerning M. kansasii genotypic characterization (Ross et al., 1992; Picardeau et al., 1997; Richter et al., 1999; Taillard et al., 2003; Chimara et al., 2004) . To date, such investigations have suggested that M. kansasii of PRA type I is the most prevalent type from clinical isolates worldwide and is only rarely isolated from the environment (Tortoli, 2003) . Through a Swiss national survey Taillard et al. (2003) confirmed the morbidity and mortality associated with type I and the role of PRA type II as an opportunistic pathogen. Clinical infection associated with other subtypes is thought to be rare.
Besides hsp65 PRA, the 16S-23S internal transcribed spacer (ITS) region is considered a useful genomic marker for the subtyping of M. kansasii (Roth et al., 1998 (Roth et al., , 2000 . Certain researchers have demonstrated that grouping into subspecies on the basis of the ITS is consistent with genotyping on the basis of hsp65 PRA (Alcaide et al., 1997; Richter et al., 1999) . The basis for the subtyping of M. kansasii by the commercially available INNO-LiPA Mycobacteria v2 test (Innogenetics, Ghent, Belgium) is ITS sequence. Although some reports have indicated that subtyping results derived from hsp65 PRA and ITS sequencing are concordant (Alcaide et al., 1997; Richter et al., 1999) , the sample number used was not sufficient to unequivocally support it. Comprehensive analysis to verify the relationship between subtyping by hsp65 PRA and ITS sequencing is required to avoid any potential ambiguities and confusion concerning clinical significance and epidemiological studies of M. kansasii based on its genotype. The aim of the present study was to compare the typing results by these two methods on M. kansasii clinical isolates in Japan in an effort to delineate the potential evolutionary link between each subtype. 
Materials and methods

Strains analyzed
PCR and restriction enzyme analysis (PRA)
PCR and restriction enzyme analysis of the hsp65 gene was performed for all isolates as previously described (Telenti et al., 1993) . Briefly, the Telenti fragment (441 bp) was amplified using primers TB11 and TB12 and digested with BstEII and HaeIII. Restriction fragment lengths were analyzed using the HITACHI microchip electrophoresis analysis system i-chip SV1210 (Hitachi electronics engineering Co. Ltd., Tokyo, Japan), which provides digital images, and banding patterns were characterized according to previously used methods (Alcaide et al., 1997; Picardeau et al., 1997) . All banding patterns obtained in this study are depicted in Fig. 1 .
Determination of the16S--23S rDNA ITS sequence
The complete ITS region was amplified using primers targeting the 3 0 -end of the 16S rRNA gene (ITS1 [5 0 -GAT TGG GAC GAA GTC GTA AC]) and the 5 0 -end of the 23S rRNA gene (ITS2 [5 0 -AGC CTC CCA CGT CCT TCA TC]) (Richter et al., 1999) . The PCR product was sequenced using an automated DNA sequencer (ABI Genetic analyzer 310, Applied Biosystems, Foster City, CA) with the ITS1 or ITS2 primer.
Determination of a partial sequence of the 16S rRNA gene A partial 16S rRNA gene fragment comprising hypervariable regions A and B was amplified using 285F (5 0 -GAG AGT TTG ATC CTG GCT CAG) and 264R (5 0 -TGC ACA CAG GCC ACA AGG GA). The PCR product was sequenced using 285F or 259R (5 0 -TTT CAC GAA CAA CGC GAC AA) (Boddinghaus et al., 1990; Kirschner et al., 1993) .
Determination of a partial sequence of the hsp65 and gyrB genes A 441-bp fragment of the hsp65 gene was amplified using TB11 and TB12 primers, and both strands of the PCR products were sequenced using the PCR primers (Telenti et al., 1993) . A partial sequence of the gyrB gene was amplified using KG632f and MK962r as described by Kasai et al. (2000) . Both strands of the 330-bp fragment between KG632f and MK962r primers were sequenced.
Nucleotide sequence accession numbers
Sequences for strains MY-1, UN-28, KM-7, KM-8, SA-11, SA-10, HS27 and SA-10 determined in this study have been deposited in the DDBJ with accession numbers AB232363, AB232364, AB232365, AB232366, AB232367, AB232368, AB232369 and AB232370, respectively.
Results and discussion
This national survey showed that clinical isolates of Mycobacterium kansasii in Japan were almost exclusively of subtype I as determined from hsp65 PRA (Table 1) . Similar results have been found in Europe (Alcaide et al., 1997; Picardeau et al., 1997; Taillard et al., 2003) , North America (Zhang et al., 2004) and Sao Paulo, Brazil (Chimara et al., 2004) .
Although our investigations yielded similar results with the subtyping methods used, four strains (two from Hokkaido, one from Chu-shikoku and one from Kyushu) showed an obvious discrepancy between the hsp65 PRA and ITS sequencing subtyping methods (Table 1) three strains displayed a previously unreported hsp65 PRA pattern, whereas its ITS sequence is type II specific (Fig. 1) . Sequence analysis of the 441-bp hsp65 gene fragment revealed 99.3% similarity to the type II sequence and one of the substitutions was located within the HaeIII recognition site, resulting in the formation of a new banding pattern. The PRA pattern was designated as type IIb given the ITS sequence and high similarity of the hsp65 gene sequence to type II. These results indicate that typing by hsp65 PRA and ITS sequencing do not necessarily yield identical results. This should be kept in mind when epidemiological studies of M. kansasii are performed. It is intriguing that the four strains (HS-12, HS-16, SA-10 and FT-12) which showed an obvious discrepancy between the two methods used indicated a type I PRA genotype but a characteristic type II 16S-23S ITS sequence (sequevar II) ( Table 2 ). The perfect match of the hsp65 gene sequence within these strains with the type I sequence confirmed that they are genuine hsp65 PRA-type I strains, and not false-type I strains that may have resulted from base substitution at the BstEII or HaeIII recognition sites (Table 2 ). These four atypical type I strains were designated as intermediate type I as they possess the type I hsp65 gene and type II ITS sequences.
The question that emerges is whether the intermediate type I strain evolved from type I or type II. Type I has been exclusively isolated from humans, while type II has been isolated from both humans and the environment, and the other types have been isolated exclusively from the environment (Tortoli, 2003) . If the evolutionary direction of M. kansasii is from type II to type I, it seems plausible that the progenitor of M. kansasii was environmental organisms that I  31  47  2  63  21  20  184  I  I I  2  0  0  0  1  1  4  IIb  II  0  0  0  0  1  2  3  II  II  2  0  1 Table 2) .
Some of the typical type II strains showed minor variants of the gyrB sequence and the ITS sequence (Table 2) . Alcaide et al. (1997) reported minor variants of the ITS sequence in type II strains. To date, the significance of the minor variants seen in typical type II strains remains unknown. A comparative analysis with other types that are exclusively of environmental origin might help to delineate the nature of the minor variants.
In conclusion, we report on the finding and characterization of novel subtypes of M. kansasii, intermediate type I and atypical type II, which is consistent with the hypothesis that clinically significant M. kansasii hsp65 PRA type I strain branched from the type II strain (opportunistic pathogen). The evolutionary scenario proposed in this study might reflect the evolution of M. kansasii species from environmental origin to close adaptation to a single host (human). The evolutionary footprint could draw attention to the possibility of human-to-human transmission of M. kansasii.
